|
RPE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.076000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.47540000000357E-05 |
| Normal-vs-Stage2 |
7.733000E-01 |
| Normal-vs-Stage3 |
3.554000E-01 |
| Normal-vs-Stage4 |
4.147600E-01 |
| Stage1-vs-Stage2 |
1.970640E-01 |
| Stage1-vs-Stage3 |
8.386500E-04 |
| Stage1-vs-Stage4 |
7.977400E-03 |
| Stage2-vs-Stage3 |
3.947400E-01 |
| Stage2-vs-Stage4 |
3.739000E-01 |
| Stage3-vs-Stage4 |
7.366200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.337200E-03 |
| Normal-vs-AfricanAmerican |
1.879810E-01 |
| Normal-vs-Asian |
6.279200E-01 |
| Caucasian-vs-AfricanAmerican |
5.234200E-01 |
| Caucasian-vs-Asian |
1.251600E-01 |
| AfricanAmerican-vs-Asian |
2.699600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.32360000000421E-05 |
| Normal-vs-Female |
3.686200E-01 |
| Male-vs-Female |
4.425900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.289900E-02 |
| Normal-vs-Extreme_Weight |
2.23109999997195E-06 |
| Normal-vs-Obese |
5.410800E-01 |
| Normal-vs-Extreme_Obese |
6.200000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.790360E-01 |
| Normal_Weight-vs-Obese |
2.725800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.652400E-01 |
| Extreme_Weight-vs-Obese |
9.759500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.470400E-01 |
| Obese-vs-Extreme_Obese |
8.250200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.882200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.424500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.029800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.883190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.292020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.758300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.038180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.298300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.861200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.375800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.8927599999996E-05 |
| Normal-VS-Type2 PRCC |
3.550400E-01 |
| Normal-VS-KIRP CIMP |
2.721400E-03 |
| Normal-VS-Unclassified PRCC |
8.985400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.334170E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.67510005866234E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
1.260360E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.83879999998893E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
6.182800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.442500E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.782100E-03 |
| Normal-vs-N1 |
1.720100E-02 |
| Normal-vs-N2 |
7.803600E-01 |
| N0-vs-N1 |
3.152400E-04 |
| N0-vs-N2 |
5.084000E-01 |
| N1-vs-N2 |
2.197400E-01 |
|
|
